Kayla Cristales

While the U.S. Department of Justice (DOJ) has identified and pursued a variety of fraud schemes and activities related to COVID-19 (such as sales of fake testing kits and PPE, price gouging, and frau...

Health Law Vitals - edition focused on Healthcare, Life Sciences, FDA and COVID-19. Browse a number of featured stories and quick reports on breaking news in this area.

After much anticipation, the FDA has begun, once again, to address its policies on cannabidiol (CBD) via:

1. FDA’s issuance of a second report to Congress regarding data collect...

A Haynes and Boone, LLP deal team represented Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) in a $25 million public offering of its common stock.

As healthcare providers respond to increased demands on supplies and resources due to the COVID-19 pandemic, regulators have issued certain flexibilities and guidance in responding to the public healt...

Today, the federal government enacted the Paycheck Protection Program and Health Care Enhancement Act (the “PPP/HCE Act”) to provide additional funding for loan and grant pro...

The Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”), a historic $2 trillion relief package signed into law on March 27, 2020, seeks to address the econom...

We recently discussed how the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) allocates $100 billion to the Public Health and Social Service Emergency Fu...

Federal and state agencies continue to deliver tools and information to help healthcare providers respond to the COVID-19 pandemic since the President declared the COVID-19 outbreak

On March 19, 2020, the FDA revised its guidance on postmarket adverse event reporting for medical products and dietary supplements during a pandemic to apply the guidance to the ongoing COVID-19...